Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Methotrexate remains mainstay
Washington - As methotrexate reaches the 50th anniversary of its first use as an antipsoriatic agent, it remains the gold standard for patients whose disease requires systemic treatment, Gerald D. Weinstein, M.D., said at the annual meeting of the American Academy of Dermatology.
Related Videos
Related Content
